Table 2.

Association Between Pretransplant Factors and Mortality After URD Transplantation

Factor Category Hazard Ratio 95% CI PValue
HLA  Match  1  
Compatibility  A or B mismatch 1.0  0.4, 2.4  1  
 DRB or DQB mismatch  2.1 1.1, 3.8  .02  
 Multiple mismatch  3.5  1.6, 7.4 .002  
CMV and  Neither  2  1.1, 3.6  .02  
Fungal Either  1  
Prophylaxis* Both  0.6  0.3, 1  .05 
Age  >50 yr  5.3  2.1, 13  <.001  
Weight ≥10% above IBW  1.8  1.1, 3.0  .02  
Disease  ≤1 yr  1  
Duration  >1 and ≤3 yr  0.8  0.5, 1.5  .6 
 >3 yr  1.5  0.8, 2.8  .2  
IFN-α  ≥6 m 2.1  1.2, 3.6  .007 
Factor Category Hazard Ratio 95% CI PValue
HLA  Match  1  
Compatibility  A or B mismatch 1.0  0.4, 2.4  1  
 DRB or DQB mismatch  2.1 1.1, 3.8  .02  
 Multiple mismatch  3.5  1.6, 7.4 .002  
CMV and  Neither  2  1.1, 3.6  .02  
Fungal Either  1  
Prophylaxis* Both  0.6  0.3, 1  .05 
Age  >50 yr  5.3  2.1, 13  <.001  
Weight ≥10% above IBW  1.8  1.1, 3.0  .02  
Disease  ≤1 yr  1  
Duration  >1 and ≤3 yr  0.8  0.5, 1.5  .6 
 >3 yr  1.5  0.8, 2.8  .2  
IFN-α  ≥6 m 2.1  1.2, 3.6  .007 

*Because of considerable overlap in the introduction of policies for CMV and fungal prophylaxis, the regimens were grouped based on no CMV or fungal prophylaxis (n = 40), CMV or fungal prophylaxis (n = 53: fungal only n = 9, CMV only n = 44), and CMV and fungal prophylaxis (n = 91).

Close Modal

or Create an Account

Close Modal
Close Modal